1. Home
  2. STAA vs GOF Comparison

STAA vs GOF Comparison

Compare STAA & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • GOF
  • Stock Information
  • Founded
  • STAA 1982
  • GOF 2006
  • Country
  • STAA United States
  • GOF United States
  • Employees
  • STAA N/A
  • GOF N/A
  • Industry
  • STAA Ophthalmic Goods
  • GOF Finance/Investors Services
  • Sector
  • STAA Health Care
  • GOF Finance
  • Exchange
  • STAA Nasdaq
  • GOF Nasdaq
  • Market Cap
  • STAA 850.9M
  • GOF 2.4B
  • IPO Year
  • STAA N/A
  • GOF N/A
  • Fundamental
  • Price
  • STAA $17.17
  • GOF $15.08
  • Analyst Decision
  • STAA Hold
  • GOF
  • Analyst Count
  • STAA 8
  • GOF 0
  • Target Price
  • STAA $27.17
  • GOF N/A
  • AVG Volume (30 Days)
  • STAA 758.1K
  • GOF 789.2K
  • Earning Date
  • STAA 08-06-2025
  • GOF 01-01-0001
  • Dividend Yield
  • STAA N/A
  • GOF 15.42%
  • EPS Growth
  • STAA N/A
  • GOF N/A
  • EPS
  • STAA N/A
  • GOF N/A
  • Revenue
  • STAA $279,134,000.00
  • GOF N/A
  • Revenue This Year
  • STAA N/A
  • GOF N/A
  • Revenue Next Year
  • STAA $27.83
  • GOF N/A
  • P/E Ratio
  • STAA N/A
  • GOF N/A
  • Revenue Growth
  • STAA N/A
  • GOF N/A
  • 52 Week Low
  • STAA $13.50
  • GOF $10.96
  • 52 Week High
  • STAA $49.86
  • GOF $16.76
  • Technical
  • Relative Strength Index (RSI)
  • STAA 49.02
  • GOF 66.93
  • Support Level
  • STAA $16.52
  • GOF $14.76
  • Resistance Level
  • STAA $18.00
  • GOF $15.10
  • Average True Range (ATR)
  • STAA 0.69
  • GOF 0.10
  • MACD
  • STAA 0.09
  • GOF 0.03
  • Stochastic Oscillator
  • STAA 53.85
  • GOF 95.76

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest

Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.

Share on Social Networks: